NRG Energy, one of the nation’s leading electricity and natural gas suppliers, has surpassed $4 million in funding to Children’s Hospital of Philadelphia (CHOP) from its charitable program, Choose to Give. The milestone was celebrated at the hospital with a check presentation which included leadership and staff from the Cardiac Center at CHOP.

The findings from the clinical trial were published in the New England Journal of Medicine.

Researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania revealed a powerful new bone marrow atlas that will offer the public a first-of-its-kind visual passport into the spectrum of healthy and diseased blood production.

Learn about two studies that evaluated COVID-19 vaccine safety. Watch “Pennsylvania: At the forefront in the prevention of infectious diseases” to learn about the major milestones and discoveries that happened in PA.

Watch as Dr. Handy describes the effectiveness of the measles vaccine and which three groups might need a booster during outbreaks.

This article deconstructs three examples of unsubstantiated talking points used in support of the vaccines and chronic diseases argument.

Target gene could serve as the basis of a future therapeutic intervention.

The study identified obstacles like limited time during clinical visits, a lack of comprehensive resources, and insufficient notice from caregivers to prepare for discussions.

In a landmark study, an international consortium led by researchers at CHOP published the final results of a key clinical trial of the gene therapy CASGEVY for the treatment of sickle cell disease.

Findings provide some of the first evidence of potential therapeutic targets for condition affecting thousands of patients with single ventricle congenital heart disease.